Survival is significantly better for patients younger than age 55. P < .0001. Figure shows estimated distributions of overall survival (Kaplan-Meier estimates) from date of registration for pentostatin therapy, by age at start of initial therapy. Tick marks indicate patients who were alive at last contact.